Bartlett & Co Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8K | Hold |
574
| – | – | ﹤0.01% | 667 |
|
|
2025
Q1 | $49.7K | Hold |
574
| – | – | ﹤0.01% | 650 |
|
|
2024
Q4 | $47.4K | Hold |
574
| – | – | ﹤0.01% | 660 |
|
|
2024
Q3 | $49.9K | Hold |
574
| – | – | ﹤0.01% | 657 |
|
|
2024
Q2 | $47.2K | Hold |
574
| – | – | ﹤0.01% | 669 |
|
|
2024
Q1 | $46K | Hold |
574
| – | – | ﹤0.01% | 678 |
|
|
2023
Q4 | $43.8K | Hold |
574
| – | – | ﹤0.01% | 732 |
|
|
2023
Q3 | $41.5K | Hold |
574
| – | – | ﹤0.01% | 691 |
|
|
2023
Q2 | $43.4K | Hold |
574
| – | – | ﹤0.01% | 695 |
|
|
2023
Q1 | $43.6K | Hold |
574
| – | – | ﹤0.01% | 590 |
|
|
2022
Q4 | $45.1K | Hold |
574
| – | – | ﹤0.01% | 596 |
|
|
2022
Q3 | $40.9K | Hold |
574
| – | – | ﹤0.01% | 594 |
|
|
2022
Q2 | $43K | Hold |
574
| – | – | ﹤0.01% | 593 |
|
|
2022
Q1 | $45.7K | Buy |
+574
| New | +$45.7K | ﹤0.01% | 593 |
|
|
2021
Q4 | – | Sell |
-624
| Closed | -$48.3K | – | 749 |
|
|
2021
Q3 | $48.3K | Buy |
624
+50
| +9% | +$3.87K | ﹤0.01% | 514 |
|
|
2021
Q2 | $46.2K | Hold |
574
| – | – | ﹤0.01% | 523 |
|
|
2021
Q1 | $45.3K | Hold |
574
| – | – | ﹤0.01% | 556 |
|
|
2020
Q4 | $41K | Hold |
574
| – | – | ﹤0.01% | 561 |
|
|
2020
Q3 | $36.7K | Hold |
574
| – | – | ﹤0.01% | 533 |
|
|
2020
Q2 | $37.1K | Hold |
574
| – | – | ﹤0.01% | 537 |
|
|
2020
Q1 | $31.6K | Hold |
574
| – | – | ﹤0.01% | 531 |
|
|
2019
Q4 | $37.1K | Hold |
574
| – | – | ﹤0.01% | 576 |
|
|
2019
Q3 | $32.5K | Hold |
574
| – | – | ﹤0.01% | 595 |
|
|
2019
Q2 | $34.5K | Hold |
574
| – | – | ﹤0.01% | 481 |
|
|
2019
Q1 | $37.4K | Hold |
574
| – | – | ﹤0.01% | 459 |
|
|
2018
Q4 | $35.8K | Hold |
574
| – | – | ﹤0.01% | 455 |
|
|
2018
Q3 | $42.2K | Hold |
574
| – | – | ﹤0.01% | 456 |
|
|
2018
Q2 | $38.6K | Hold |
574
| – | – | ﹤0.01% | 451 |
|
|
2018
Q1 | $35.8K | Buy |
+574
| New | +$35.8K | ﹤0.01% | 461 |
|